Vision

neoplas med
For a world in where every wound
can be treated effectively

“neoplas med contributes to the solution of two global challenges for the health systems: With our innovative plasma jet technology we can increase the efficiency of wound treatment and support the fight against multi-resistant germs. To this end we are in close cooperation with researchers and doctors in order to effectively support the healing process of patients and to give them a new quality of life.”
ULRIKE SAILER, Managing Partner


High precision solutions for effective wound management

neoplas med is continuously expanding the fascinating application possibilities of cold plasma in medicine, which means that it is working on the improvement of the quality of life of people. The company develops high precision medical devices for the pinpoint application of cold physical plasma with a pioneering spirit, a consistent focus on the practical application, and in close cooperation with research.

An important milestone: kINPen® MED, the first CE-marked atmospheric pressure plasma jet with a medical device approval for the treatment of wounds and pathogen-induced skin disorders.
neoplas med already makes it possible for doctors and hospitals to treat a wide range of wounds with unique precision and in a way that is largely pain-free, effective and easy – so far without any known side effects or development of resistance.

In close contact with research
neoplas med was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e. V. (INP) in Greifswald, Germany. It is an emerging and innovative company which manufactures its products regionally in Mecklenburg-Western Pomerania. The neoplas med products are sold internationally with the “Made in Germany” seal of quality.
INP Greifswald is the largest non-university institute for the research of low temperature plasmas throughout Europe. In the field of plasma medicine, the institute is on eye level with the most renowned research institutions worldwide.